Shares of bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $113.87 and traded as low as $112.89. bioMérieux shares last traded at $112.89, with a volume of 9,557 shares trading hands.
Analysts Set New Price Targets
Separately, UBS Group raised bioMérieux to a “strong-buy” rating in a research note on Thursday, August 22nd.
View Our Latest Report on bioMérieux
bioMérieux Stock Performance
About bioMérieux
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Featured Stories
- Five stocks we like better than bioMérieux
- Pros And Cons Of Monthly Dividend Stocks
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- Trading Stocks: RSI and Why it’s Useful
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- With Risk Tolerance, One Size Does Not Fit All
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.